A simplified flow cytometric method for detection of inherited platelet disorders-A comparison to the gold standard light transmission aggregometry.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2019
2019
Historique:
received:
19
07
2018
accepted:
08
01
2019
entrez:
24
1
2019
pubmed:
24
1
2019
medline:
23
10
2019
Statut:
epublish
Résumé
Flow cytometric platelet activation has emerged as an alternative diagnostic test for inherited platelet disorders. It is, however, labor intensive and few studies have directly compared the performance of flow cytometric platelet activation (PACT) to light transmission aggregometry (LTA). The aims of this study were 1/ to develop a simplified flow cytometric platelet activation assay using microtiter plates and 2/ to correlate the outcome to gold standard method LTA, and to clinical bleeding assessment tool scores (BAT score). The PACT method was developed in microtiter plates using adenosine diphosphate (ADP), collagen-derived peptide (CRP-XL) and thrombin receptor activator for peptide 6 (TRAP-6) as agonists. Antibodies against GPIIb-IIIa activation epitope (PAC1), P-selectin (CD62P) and lysosome-associated membrane glycoprotein 3 (LAMP3; CD63) were used as platelet activation markers. Sixty-six patients referred to the coagulation unit for bleeding symptoms were included in this single-center observational study. Platelet activation was determined by PACT and LTA. The results of both methods were correlated to BAT score. A two-by-two analysis using Cohen's kappa analysis gave moderate agreement between LTA and PACT (82%, kappa = 0.57), when PACT analysis with ADP and CRP-XL was compared to LTA. Using LTA as reference method, positive predictive value was 70% and negative predictive value was 87%. A substantial number of patients had high BAT score and normal LTA and PACT results. Patients with abnormal LTA or PACT results had higher BAT score than patients with normal results, but the difference was not significant. The performance in microtiter plates simplified the PACT method and enabled analysis of more patients at the same time. Our results indicate that with modification of the current PACT assay, a higher negative predictive value can be obtained. Furthermore, with comparable result to LTA the PACT could be used as a screening assay for inherited platelet disorders.
Sections du résumé
BACKGROUND
Flow cytometric platelet activation has emerged as an alternative diagnostic test for inherited platelet disorders. It is, however, labor intensive and few studies have directly compared the performance of flow cytometric platelet activation (PACT) to light transmission aggregometry (LTA). The aims of this study were 1/ to develop a simplified flow cytometric platelet activation assay using microtiter plates and 2/ to correlate the outcome to gold standard method LTA, and to clinical bleeding assessment tool scores (BAT score).
METHODS
The PACT method was developed in microtiter plates using adenosine diphosphate (ADP), collagen-derived peptide (CRP-XL) and thrombin receptor activator for peptide 6 (TRAP-6) as agonists. Antibodies against GPIIb-IIIa activation epitope (PAC1), P-selectin (CD62P) and lysosome-associated membrane glycoprotein 3 (LAMP3; CD63) were used as platelet activation markers. Sixty-six patients referred to the coagulation unit for bleeding symptoms were included in this single-center observational study. Platelet activation was determined by PACT and LTA. The results of both methods were correlated to BAT score.
RESULTS
A two-by-two analysis using Cohen's kappa analysis gave moderate agreement between LTA and PACT (82%, kappa = 0.57), when PACT analysis with ADP and CRP-XL was compared to LTA. Using LTA as reference method, positive predictive value was 70% and negative predictive value was 87%. A substantial number of patients had high BAT score and normal LTA and PACT results. Patients with abnormal LTA or PACT results had higher BAT score than patients with normal results, but the difference was not significant.
CONCLUSIONS
The performance in microtiter plates simplified the PACT method and enabled analysis of more patients at the same time. Our results indicate that with modification of the current PACT assay, a higher negative predictive value can be obtained. Furthermore, with comparable result to LTA the PACT could be used as a screening assay for inherited platelet disorders.
Identifiants
pubmed: 30673773
doi: 10.1371/journal.pone.0211130
pii: PONE-D-18-20846
pmc: PMC6343919
doi:
Types de publication
Comparative Study
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0211130Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Blood. 1998 Jan 15;91(2):491-9
pubmed: 9427702
J Thromb Haemost. 2011 Jul;9 Suppl 1:76-91
pubmed: 21781244
Platelets. 2018 Jul;29(5):512-519
pubmed: 28895772
J Thromb Haemost. 2015 Feb;13(2):314-22
pubmed: 25403439
Platelets. 2015;26(7):699-701
pubmed: 25902305
Br J Haematol. 1994 Mar;86(3):574-82
pubmed: 8043439
Platelets. 2018 Nov;29(7):644-649
pubmed: 29537938
Platelets. 2016;27(1):66-74
pubmed: 25901600
J Clin Pathol. 1988 Dec;41(12):1322-30
pubmed: 3225335
J Thromb Haemost. 2018 Apr;16(4):689-698
pubmed: 29337406
J Thromb Haemost. 2013 Apr 10;:
pubmed: 23574625
PLoS One. 2015 Jun 09;10(6):e0129666
pubmed: 26058047
Int J Lab Hematol. 2018 May;40 Suppl 1:6-14
pubmed: 29741250
J Lab Clin Med. 1987 Sep;110(3):346-54
pubmed: 3475397
Semin Thromb Hemost. 2016 Apr;42(3):185-90
pubmed: 26886396
J Thromb Haemost. 2014 Sep;12(9):1562-9
pubmed: 24976115
Int J Lab Hematol. 2018 May;40 Suppl 1:34-45
pubmed: 29741257
Pathophysiol Haemost Thromb. 2006;35(1-2):67-82
pubmed: 16855350
Blood Rev. 2007 Mar;21(2):89-97
pubmed: 16774804
J Thromb Haemost. 2014 May;12(5):660-5
pubmed: 24618131
Platelets. 2018 May;29(3):270-276
pubmed: 28409645